1-3 of 3
Ingrid B.J. Joseph
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Discovery and Preclinical Development of ASG-5ME, an Antibody–Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer

Michael Mattie, Arthur Raitano, Kendall Morrison, Karen Morrison, Zili An, Linnette Capo, Alla Verlinsky, Monica Leavitt, Jimmy Ou, Rossana Nadell, Hector Aviña, Claudia Guevara, Faisal Malik, Ruth Moser, Steven Duniho, Jeffrey Coleman, Ying Li, Daniel S. Pereira, Fernando Doñate, Ingrid B.J. Joseph, Pia Challita-Eid, Dennis Benjamin, David R. Stover
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2016) 15 (11): 2679–2687.
https://doi.org/10.1158/1535-7163.MCT-16-0225
Published: 01 November 2016
View articletitled, The Discovery and Preclinical Development of ASG-5ME, an Antibody–Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer
Open the PDF for The Discovery and Preclinical Development of ASG-5ME, an Antibody–Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker

Kendall Morrison, Pia M. Challita-Eid, Arthur Raitano, Zili An, Peng Yang, Joseph D. Abad, Wendy Liu, Dawn Ratay Lortie, Josh T. Snyder, Linnette Capo, Alla Verlinsky, Hector Aviña, Fernando Doñate, Ingrid B.J. Joseph, Daniel S. Pereira, Karen Morrison, David R. Stover
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2016) 15 (6): 1301–1310.
https://doi.org/10.1158/1535-7163.MCT-15-0570
Published: 02 June 2016
View articletitled, Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker
Open the PDF for Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6, a New Urothelial Cancer Biomarker in another window
Includes: Supplementary data
Journal Articles

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML

Daniel S. Pereira, Claudia I. Guevara, Liqing Jin, Nathan Mbong, Alla Verlinsky, Ssucheng J. Hsu, Hector Aviña, Sher Karki, Joseph D. Abad, Peng Yang, Sung-Ju Moon, Faisal Malik, Michael Y. Choi, Zili An, Kendall Morrison, Pia M. Challita-Eid, Fernando Doñate, Ingrid B.J. Joseph, Thomas J. Kipps, John E. Dick, David R. Stover
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7): 1650–1660.
https://doi.org/10.1158/1535-7163.MCT-15-0067
Published: 06 July 2015
View articletitled, AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML
Open the PDF for AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML in another window
Includes: Supplementary data